AXL was shown to be highly expressed in metastatic prostate cancer and its interaction with Gas6 was suggested to play a role in establishing tumor dormancy in the bone marrow microenvironment [29]. The gene discussed is GAS6; the disease is metastatic prostate carcinoma.